2012
DOI: 10.1590/s0066-782x2012005000084
|View full text |Cite
|
Sign up to set email alerts
|

Avaliação da doença vascular do enxerto no transplante cardíaco: experiência de um centro brasileiro

Abstract: Background: Cardiac transplantation continues to be the treatment of choice for heart failure refractory to optimized treatment. Two methods have high sensitivity for diagnosing allograft rejection episodes and cardiac allograft vasculopathy (CAV), important causes of mortality after transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
(53 reference statements)
0
1
0
Order By: Relevance
“…[3][4][5] Since the early 1990's and especially in the last decade, numerous studies have been published describing, improving and validating the IVUS measurements of maximal intimal thickness as a predictor of poor prognosis when greater than 0.5mm. [6][7][8][9][10][11] In 2010, the International Society for Heart and Lung Transplantation (ISHLT) standardized a nomenclature for CAV based on its angiographic severity. This classification, ranging from CAV0 to CAV3, according to severity and importance, takes into account graft dysfunction, which can reclassify CAV from CAV1 or CAV2 to CAV3.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5] Since the early 1990's and especially in the last decade, numerous studies have been published describing, improving and validating the IVUS measurements of maximal intimal thickness as a predictor of poor prognosis when greater than 0.5mm. [6][7][8][9][10][11] In 2010, the International Society for Heart and Lung Transplantation (ISHLT) standardized a nomenclature for CAV based on its angiographic severity. This classification, ranging from CAV0 to CAV3, according to severity and importance, takes into account graft dysfunction, which can reclassify CAV from CAV1 or CAV2 to CAV3.…”
Section: Discussionmentioning
confidence: 99%